Comparing mindfulness and relaxation techniques for treating alcohol use disorder
Official title: Comparison of the Effectiveness of Two Psycho-physical Interventions: Mindfulness Based Relapse Prevention (MBRP) and Unguided Meditative Relaxation in Patients With Alcohol Use Disorder
Run by Centre Hospitalier Universitaire de Nīmes · NCT04598399 · Data updated 2026-11-12
This study is testing whether a mindfulness program can help people with alcohol use disorder stay sober better than a simple relaxation technique.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 168 (estimated) |
| Sponsor | Centre Hospitalier Universitaire de Nīmes Academic / other |
| Locations | 7 sites (Angers and 6 other locations) |
| Status | Recruiting |
| Started | October 20, 2021 |
| Main results expected | January 2026 |
| Study ends | January 2027 |
| Registry record updated | August 21, 2025 |
| Trial ID | NCT04598399 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals with moderate to severe alcohol use disorder who have not consumed alcohol in the last 60 days.
✕Probably not a fit
Patients with severe depression, schizophrenia, or significant cognitive impairments may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effectiveness of two psycho-physical interventions, Mindfulness Based Relapse Prevention (MBRP) and unguided meditative relaxation, in patients with alcohol use disorder (AUD). The researchers aim to determine whether MBRP is more effective than a relaxation program in preventing relapse among individuals who have recently reduced their alcohol consumption. Participants must meet specific criteria related to their alcohol use and mental health status to be eligible for the study. The study is conducted at multiple locations in France, focusing on patients who have experienced moderate to severe AUD.
Why it matters
Potential benefit: If successful, this study could provide a new, effective non-pharmacological treatment option for patients struggling with alcohol use disorder.
How similar studies have gone: Other studies have shown promising results for mindfulness-based interventions in addiction treatment, suggesting potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Having a moderate to severe alcohol use disorder according to DSM 5 criteria. * The last drink must have been consumed at most in the last 60 days before the pre-inclusion visit. The patient must have had at least 1 HDD during the last drinking period Exclusion Criteria: * Severe depression (Beck Depression Inventory\> 30) * Schizophrenic disorder, * Current maniac or hypomaniac episode, * Patient with dementia or severe cognitive impairment that would prevent him/her from following the course of a session, as judged by the clinician. * Insufficient French understanding to complete the questionnaires * Pregnant or breastfeeding woman * Absence of social security regimen * Other mindfulness-based structured therapies * Refusal to sign the written consent. • The patient is under safeguard of justice or state guardianship
Where it's running
-
Ssra Les Eumenides
Angers, France Recruiting -
CHU de Nantes
Nantes, France Recruiting -
CHU de Nimes
Nîmes, France Recruiting -
Hôpital Corentin-Celton
Issy-les-Moulineaux, France Not yet recruiting -
Hopital Fernand Widal
Paris, France Not yet recruiting -
Hopital Des 4 Villes
Sèvres, France Not yet recruiting
Show 1 more location
-
Hopital Paul Brousse
Villejuif, France Not yet recruiting
Study contacts
- Principal investigator: Amandine Luquiens — CHU Nimes
- Study coordinator: Amandine Luquiens
- Email: Amandine.luquiens@chu-nimes.fr
- Phone: 04.66.68.69.98
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Imaging Mitochondrial Complex-I and Brain Metabolism in Alcohol Use Disorder
This study tests whether PET imaging with [18F]BCPP-EF and [18F]FDG can reveal differences in brain energy use between adults with alcohol use disorder and healthy controls, and whether these measures relate to relapse risk.
-
Endurance exercise to see if it lowers alcohol use in adults with AUD and ALD
A 12-week home-based cycling program added to standard care is tested to see if it reduces alcohol use and cravings in adults with alcohol use disorder and alcohol-related liver disease.
-
Do beverage cues drive craving in adults with AUD
In adults with alcohol use disorder, this study tests whether different non-alcoholic beverage cues can trigger cravings differently when people see and smell them without drinking.
-
Semaglutide for Alcohol Use Disorder and Obesity: Testing 1.0 mg and 2.0 mg vs Placebo
We’re testing two doses of semaglutide to see if they reduce alcohol craving and use in adults with alcohol use disorder and obesity compared with placebo.
-
TRIS: a mobile app with breathalyzer to support sobriety in alcohol use disorder
A smartphone app with a connected breathalyzer tests for abstinence and uses small financial incentives to encourage sobriety for adults with AUD in Brazil.
-
Body-focused mindfulness added to inpatient alcohol use disorder treatment
This trial tests whether a body-focused mindfulness program can help people with alcohol use disorder feel more connected to their bodies and reduce cravings while in inpatient care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.